Field of scientific activity:
Hematology, coagulation, transplantology. Among others, there are conducted molecular studies in myeloproliferative neoplasms which are applied for formulation of new standards in the targeted therapy for such disorders. The team is also engaged in studies of hematopoietic chimerysm after allogenic bone narrow transplantation.
Main achievements:
Hematopoietic stem cells transplantation (HSCT) mplemented into clinical practice. The implementation of Treg lymphocytes for the treatment of graft-versus-host disease.
Scientific and service offer:
The Department takes part in clinical trials phase II and III aiming at optimization of the therapy of hematological disorders.
International Projects:
2004: Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe – 6 FP – LeukemiaNet
2005: Creation of a multilingual web-based network for interactive continuing education for health professional performing basic haematological tests – Leonardo da Vinci – e-HEMATimage
2008: European Treatment and Outcome Study for CML – EUTOS
Contact details:
Department of Haematology and Transplantology
Prof. Andrzej Hellmann, M.D., Ph.D.
andrzej.hellmann@gumed.edu.pl
+ 48 58 349 22 30